UPDATE: Morgan Stanley Lowering Price Target on MetLife

Symbols: MET
Share

Morgan Stanley is out with a research report on MetLife (NYSE: MET) and it has an Overweight rating on shares, but is lowering its price target to $47 from $53.

Shares of MET gained 18 cents yesterday to close at $30.58.


 
 
< Previous
Piper Jaffray Maintains Overweight Rating and $68 PT on Coinstar
Next >
Citi Initiates Coverage on Agco with a Neutral Rating
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust